Specialties:

Most Popular Reports:

Newest Reports:

Urology and Gynecology: Trends in Medical Devices

A Survey of Fifty-five Urologists

May 2007

 

Study Description

Respondent Type

Physicians

Specialties Covered

Urology & Gynecology

Region

United States Only

Methodology

Online, self-administered survey

Approximately ten to 30 minutes duration, dependent upon specialty

Fifty-five total respondents

Fielded online from May 7 to May 10, 2007

Objectives

Assess recent trends in medical device usage and pricing in urology and gynecology for the following conditions: urinary incontinence (male and female), uterine/vaginal prolapse, uterine health and permanent sterilization, obstructive and non-obstructive benign prostatic hyperplasia, and erectile dysfunction.  Additionally;

§    Identify usage patterns of medical devices in urology and gynecology

§    Determine recent trends in pricing and reimbursement

§    Clarify drivers of usage for each physician specialty

§    Compare devices in each category based on a set of attributes

§    Assess the potential for future usage of these devices

§    Identify new and promising treatments for these conditions

Companies and Products Mentioned in This Report 

Company

Ticker Symbol

Product(s)

American Medical Systems Holdings Inc.

AMMD

AMS Dura II

Malleable 650/600M

Ethicon/Johnson & Johnson

JNJ

The Indigo Laser System

Medtronic Inc.

MDT

Prostiva TUNA

Urologix Inc.

ULGX

Targis TUMT

AMS

 

Greenlight

TherMatrx

Ambicor 2-piece & 700 MS Tactile Pump

 Inclusion Criteria and Respondent Demographics

Inclusion Criteria

 

§    US-based board certified or eligible urologists, gynecologists & prostate/colorectal surgeons

§    Two to 30 years of experience post-residency

§    Spends at least 50% of professional time in clinical practice

§    Performs at least one specified procedure type per month, on average

 

Download this report

 

 

> about us      > contact us
© Panel Intelligence, LLC. 1999-2008. All rights reserved.
A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR)
Privacy Policy